Vaccination News

A White House representative said during a press conference today that “more than enough” COVID-19 vaccine doses were being distributed for the country’s 20 million infants and toddlers.

The CDC’s Advisory Committee on Immunization Practices voted unanimously on Wednesday to recommend enhanced influenza vaccines for older Americans, introduce a second MMR vaccine, and OK a 15-valent pneumococcal vaccine for children.

Wastewater surveillance has detected “several” closely related vaccine-derived polioviruses in London sewage, suggesting there has been some person-to-person spread, health officials said.

Merck announced Wednesday that the FDA approved an expanded indication for Vaxneuvance, the company’s 15-valent pneumococcal conjugate vaccine, to include its use in infants and children aged 6 weeks to 17 years.

Paxlovid lowered the risk for severe COVID-19 or death by 46% in a study of patients in Israel and was especially effective among older or immunosuppressed patients, or patients with underlying neurological or cardiovascular diseases.

A study of nearly 34,000 patients who received a COVID-19 vaccine but experienced a breakthrough infection showed that they were still at risk for developing long COVID symptoms.

Older age and lower illness severity are associated with a higher risk for persistent Ebola virus in semen, according to a study published in Clinical Infectious Diseases.

The FDA announced Friday that it authorized the emergency use of Moderna and Pfizer-BioNTech’s COVID-19 vaccines for children as young as 6 months old.

Vaccination may not fully protect people from long COVID symptoms if they experience a breakthrough infection, according to a study published recently in Nature Medicine.

An FDA advisory committee on Wednesday unanimously recommended that Moderna and Pfizer-BioNTech’s COVID-19 vaccines be authorized for children as young as 6 months old.